SEARCH

SEARCH BY CITATION

References

  • 1
    Lantz GC . Treatment of gastric dilatation-volvulus. In: Bojrab JM , ed. Current Techniques in Small Animal Surgery, 4th ed. Baltimore, MD: Williams & Wilkins; 1998:223231.
  • 2
    Monnet E . Gastric dilatation-volvulus syndrome in dogs. Vet Clin North Am Small Anim Pract 2003;33:9871005.
  • 3
    Rasmussen L . Stomach. In: Slatter D , ed. Textbook of Small Animal Surgery, 3rd ed. Philadelphia, PA: Saunders; 2003:592634.
  • 4
    Zatloukal J , Crha M , Lexmaulova L , et al. Gastric dilatation volvulus syndrome: Outcome and factors associated with perioperative mortality. Acta Vet Brno 2005;74:621631.
  • 5
    Brockman DJ , Washabau RJ , Drobatz KJ . Canine gastric dilatation/volvulus syndrome in a veterinary critical care unit: 295 cases (1986–1992). J Am Vet Med Assoc 1995;207:460464.
  • 6
    Mackenzie G , Barnhart M , Kennedy S , et al. A retrospective study of factors influencing survival following surgery for gastric dilatation-volvulus syndrome in 306 dogs. J Am Anim Hosp Assoc 2010;46:97102.
  • 7
    Beck JJ , Staatz AJ , Pelsue DH , et al. Risk factors associated with short-term outcome and development of perioperative complications in dogs undergoing surgery because of gastric dilatation-volvulus: 166 cases (1992–2003). J Am Vet Med Assoc 2006;229:19341939.
  • 8
    Brourman JD , Schertel ER , Allen DA , et al. Factors associated with perioperative mortality in dogs with surgically managed gastric dilatation-volvulus: 137 cases (1988–1993). J Am Vet Med Assoc 1996;208:18551858.
  • 9
    Zacher LA , Berg J , Shaw SP , et al. Association between outcome and changes in plasma lactate concentration during presurgical treatment in dogs with gastric dilatation-volvulus: 64 cases (2002–2008). J Am Vet Med Assoc 2010;236:892897.
  • 10
    Buber T , Saragusty J , Ranen E , et al. Evaluation of lidocaine treatment and risk factors for death associated with gastric dilatation and volvulus in dogs: 112 cases (1997–2005). J Am Vet Med Assoc 2007;230:13341339.
  • 11
    Glickman LT , Lantz GC , Schellenberg DB , et al. A prospective study of survival and recurrence following the acute gastric dilatation-volvulus syndrome in 136 dogs. J Am Anim Hosp Assoc 1998;34:253259.
  • 12
    de Papp E , Drobatz KJ , Hughes D . Plasma lactate concentration as a predictor of gastric necrosis and survival among dogs with gastric dilatation-volvulus: 102 cases (1995–1998). J Am Vet Med Assoc 1999;215:4952.
  • 13
    Schober KE , Cornand C , Kirbach B , et al. Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus. J Am Vet Med Assoc 2002;221:381388.
  • 14
    Millis DL , Hauptman JG , Fulton RB Jr . Abnormal hemostatic profiles and gastric necrosis in canine gastric dilatation-volvulus. Vet Surg 1993;22:9397.
  • 15
    Leib MS , Wingfield WE , Twedt DC , et al. Plasma gastrin immunoreactivity in dogs with acute gastric dilatation-volvulus. J Am Vet Med Assoc 1984;185:205208.
  • 16
    Green TI , Tonozzi CC , Kirby R , et al. Evaluation of initial plasma lactate values as a predictor of gastric necrosis and initial and subsequent plasma lactate values as a predictor of survival in dogs with gastric dilatation-volvulus: 84 dogs (2003–2007). J Vet Emerg Crit Care 2011;21:3644.
  • 17
    Suchodolski JS , Steiner JM , Ruaux CG , et al. Purification and partial characterization of canine pepsinogen A and B. Am J Vet Res 2002;63:15851590.
  • 18
    di Mario F , Cavallaro LG . Non-invasive tests in gastric diseases. Dig Liver Dis 2008;40:523530.
  • 19
    Gritti I , Banfi G , Roi GS . Pepsinogens: Physiology, pharmacology pathophysiology and exercise. Pharmacol Res 2000;41:265281.
  • 20
    Mukoubayashi C , Yanaoka K , Ohata H , et al. Serum pepsinogen and gastric cancer screening. Intern Med 2007;46:261266.
  • 21
    Banga-Mboko H , Sulon J , Closset J , et al. An improved radioimmunoassay for measurement of pepsinogen in porcine blood samples. Vet J 2003;165:288295.
  • 22
    Miki K . Gastric cancer screening using the serum pepsinogen test method. Gast Cancer 2006;9:245253.
  • 23
    Suchodolski JS , Steiner JM , Ruaux CG , et al. Serum concentrations of pepsinogen A in healthy dogs after food deprivation and after feeding. Am J Vet Res 2003;64:11461150.
  • 24
    Stevenson CK , Kidney BA , Duke T , et al. Evaluation of the Accutrend for lactate measurement in dogs. Vet Clin Path 2007;36:261266.
  • 25
    Swets JA . Measuring the accuracy of diagnostic systems. Science 1988;240:12851293.
  • 26
    Charlier J , Dorny P , Levecke B , et al. Serum pepsinogen levels to monitor gastrointestinal nematode infections in cattle revisited. Res Vet Sci 2011;90:451456.
  • 27
    Berghen P , Dorny P , Vercruysse J . Evaluation of a simplified blood pepsinogen assay. Am J Vet Res 1987;48:664669.
  • 28
    Schaw DJ , Vercruysse J , Claerebout E , et al. Gastrointestinal nematode infections of first-season grazing calves in Belgium: General patterns and the effect of chemoprophylaxis. Vet Parasitol 1997;69:103116.
  • 29
    Scott I , Dick A , Irvine J , et al. The distribution of pepsinogen within the abomasa of cattle and sheep infected with Ostertagia spp. and sheep infected with Haemonchus contortus. Vet Parasitol 1999;82:145159.
  • 30
    Bouzeid NZ , Sakuta E , Kawai T , et al. Assessment of serum pepsinogen and other biochemical parameters in dairy cows with displaced abomasums or abomasal volvulus before and after operation. J Rakuno Gakuen Univ 2008;32:161167.
  • 31
    Zadnik T , Mesaric M . Fecal blood levels and serum proenzyme pepsinogen activity of dairy cows with abomasal displacement. Isr J Vet Med 1999;3:6165.
  • 32
    Banga-Mboko H , Tamboura H , Maes D , et al. Survey of gastric lesions and blood pepsinogen levels in pigs in Burkina Faso. Vet Res Commun 2003;27:595602.
  • 33
    Wilson JH , Pearson MM . Serum pepsinogen levels in foals with gastric or duodenal ulcers. Equine Pract 1986;51:149155.
  • 34
    Matthiesen DT . Gastric dilatation-volvulus syndrome. In: Slatter D , ed. Textbook of Small Animal Surgery, 2nd ed. Philadelphia, PA: WB Saunders; 1993;580591.
  • 35
    Steiner JM , Newman S , Xenoulis P , et al. Sensitivity of serum markers for pancreatitis in dogs with macroscopic evidence of pancreatitis. Vet Ther 2008;9:263273.
  • 36
    Kathrani A , Steiner JM , Suchodolski J , et al. Elevated canine pancreatic lipase immunoreactivity concentration in dogs with inflammatory bowel disease is associated with a negative outcome. J Small Anim Pract 2009;50:126132.
  • 37
    Trivedi S , Marks SL , Kass JA , et al. Sensitivity and specificity of canine pancreas-specific lipase (cPL) and other markers for pancreatitis in 70 dogs with and without histopathologic evidence of pancreatitis. J Vet Intern Med 2011;25:12411247.
  • 38
    Neilson-Carley SC , Robertson JE , Newman SJ , et al. Specificity of a canine pancreas-specific lipase assay for diagnosing pancreatitis in dogs without clinical or histologic evidence of this disease. Am J Vet Res 2011;72:302307.
  • 39
    Carney PC , Ruaux CG , Suchodolski JS , et al. Biological variability of C-reactive protein and specific canine pancreatic lipase immunoreactivity in apparently healthy dogs. J Vet Intern Med 2011;25:825830.
  • 40
    Steiner JM . Diagnosis of pancreatitis. Vet Clin North Am Small Anim Pract 2003;33:11811195.
  • 41
    Plickert HD , Einspanier R , Arndt G , et al. Evaluation of a point-of-care test for canine C-reactive protein. Vet Clin Pathol 2011;40:384388.
  • 42
    Mukorera V , Dvir E , van der Merwe LL , et al. Serum C-reactive protein concentration in benign and malignant canine spirocercosis. J Vet Intern Med 2011;25:963966.
  • 43
    Galezowski AM , Snead EC , Kidney BA , et al. C-reactive protein as a prognostic indicator in dogs with acute abdomen syndrome. J Vet Diagn Invest 2010;22:395401.
  • 44
    Köster LS , Van Schoor M , Goddard A , et al. C-reactive protein in canine babesiosis caused by Babesia rossi and its association with outcome. J S Afr Vet Assoc 2009;80:8791.
  • 45
    Gebhardt C , Hirschberger J , Rau S , et al. Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis. J Vet Emerg Crit Care 2009;19:450458.
  • 46
    Whittemore JC , Marcum BA , Mawby DI , et al. Associations among albuminuria, C-reactive protein concentrations, survival predictor index scores, and survival in 78 critically ill dogs. J Vet Intern Med 2011;25:818824.
  • 47
    Mylonakis ME , Ceron JJ , Leontides L , et al. Serum acute phase proteins as clinical phase indicators and outcome predictors in naturally occurring canine monocytic ehrlichiosis. J Vet Intern Med 2011;25:811817.
  • 48
    Griebsch C , Arndt G , Raila J , et al. C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia. Vet Clin Pathol 2009;38:421425.
  • 49
    Mitchell KD , Kruth SA , Wood RD , et al. Serum acute phase protein concentrations in dogs with autoimmune hemolytic anemia. J Vet Intern Med 2009;23:585591.
  • 50
    Chan DL , Rozanski EA , Freeman LM . Relationship among plasma amino acids, C-reactive protein, illness severity, and outcome in critically ill dogs. J Vet Intern Med 2009;23:559563.